Palatin Technologies, Inc.

DB:PTN Stock Report

Market Cap: €18.2m

Palatin Technologies Past Earnings Performance

Past criteria checks 0/6

Palatin Technologies's earnings have been declining at an average annual rate of -31.4%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 66.5% per year.

Key information

-31.4%

Earnings growth rate

-27.5%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate-66.5%
Return on equityn/a
Net Margin-1,357.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Palatin Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:PTN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242-32110
30 Jun 244-30120
31 Mar 246-31130
31 Dec 237-32150
30 Sep 236-21150
30 Jun 235-24150
31 Mar 234-27170
31 Dec 223-26160
30 Sep 222-37160
30 Jun 221-36170
31 Mar 221-37160
31 Dec 211-35170
30 Sep 210-37190
30 Jun 210-34170
31 Mar 210-27150
31 Dec 200-27130
30 Sep 200-22100
30 Jun 200-22100
31 Mar 206037100
31 Dec 196037100
30 Sep 19603790
30 Jun 196036100
31 Mar 1921-590
31 Dec 18300100
30 Sep 1840890
30 Jun 18672590
31 Mar 18802680
31 Dec 178223100
30 Sep 177210100
30 Jun 1745-13100
31 Mar 1711-40100
31 Dec 160-4960
30 Sep 160-5260
30 Jun 160-5260
31 Mar 160-5060
31 Dec 150-4760
30 Sep 158-3160
30 Jun 1513-1860
31 Mar 1513-1050
31 Dec 1413-250
30 Sep 145-950
30 Jun 140-1450
31 Mar 140-14511

Quality Earnings: PTN is currently unprofitable.

Growing Profit Margin: PTN is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PTN is unprofitable, and losses have increased over the past 5 years at a rate of 31.4% per year.

Accelerating Growth: Unable to compare PTN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PTN is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.2%).


Return on Equity

High ROE: PTN's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 16:13
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Palatin Technologies, Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John NewmanCanaccord Genuity
Joseph PantginisH.C. Wainwright & Co.
Kumaraguru RajaNOBLE Capital Markets, Inc.